Mark E.  Nance net worth and biography

Mark Nance Biography and Net Worth

General Counsel of Envista
As General Counsel for Envista, Mark Nance leads the corporate legal team.

Mark joined Envista in 2019 from INSYS Therapeutics, Inc., where he was most recently Chief Legal Officer and General Counsel. He has nearly 20 years of General Counsel expertise. 

Prior to joining Envista, Mark held roles as General Counsel for Mylan, N.V., a global pharmaceutical leader, and led the legal teams at G.E. Healthcare Medical Diagnostics and G.E. Healthcare Life Sciences. He also worked in the Office of Policy Planning at the U.S. Federal Trade Commission. Mark served as a commissioned officer in the U.S. Marine Corps. 

Mark holds a BA in Political Science from the University of Missouri and a JD from Cornell Law School.

What is Mark E. Nance's net worth?

The estimated net worth of Mark E. Nance is at least $835,108.38 as of November 8th, 2023. Mr. Nance owns 39,042 shares of Envista stock worth more than $835,108 as of March 29th. This net worth evaluation does not reflect any other investments that Mr. Nance may own. Additionally, Mr. Nance receives an annual salary of $753,640.00 as General Counsel at Envista. Learn More about Mark E. Nance's net worth.

How old is Mark E. Nance?

Mr. Nance is currently 55 years old. There are 4 older executives and no younger executives at Envista. The oldest executive at Envista is Mr. Amir Aghdaei, President, CEO & Director, who is 65 years old. Learn More on Mark E. Nance's age.

What is Mark E. Nance's salary?

As the General Counsel of Envista Holdings Co., Mr. Nance earns $753,640.00 per year. The highest earning executive at Envista is Mr. Amir Aghdaei, President, CEO & Director, who commands a salary of $3,420,000.00 per year. Learn More on Mark E. Nance's salary.

How do I contact Mark E. Nance?

The corporate mailing address for Mr. Nance and other Envista executives is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. Envista can also be reached via phone at 714-817-7000 and via email at [email protected]. Learn More on Mark E. Nance's contact information.

Has Mark E. Nance been buying or selling shares of Envista?

Mark E. Nance has not been actively trading shares of Envista over the course of the past ninety days. Learn More on Mark E. Nance's trading history.

Who are Envista's active insiders?

Envista's insider roster includes Amir Aghdaei (CEO), Curt Bludworth (Insider), Eric Conley (SVP), Jeffrey Kappler (SVP), Stephen Keller (Principal Financial Officer), Mark Nance (General Counsel), Mischa Reis (SVP), and Howard Yu (CFO). Learn More on Envista's active insiders.

Are insiders buying or selling shares of Envista?

During the last twelve months, Envista insiders bought shares 4 times. They purchased a total of 19,185 shares worth more than $417,124.65. The most recent insider tranaction occured on November, 16th when SVP Eric Conley bought 2,185 shares worth more than $50,014.65. Insiders at Envista own 1.2% of the company. Learn More about insider trades at Envista.

Information on this page was last updated on 11/16/2023.

Mark E. Nance Insider Trading History at Envista

See Full Table

Mark E. Nance Buying and Selling Activity at Envista

This chart shows Mark E. Nance's buying and selling at Envista by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Envista Company Overview

Envista logo
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Read More

Today's Range

Now: $21.39
Low: $21.24
High: $21.62

50 Day Range

MA: $22.33
Low: $20.64
High: $24.53

2 Week Range

Now: $21.39
Low: $20.00
High: $40.92

Volume

1,380,479 shs

Average Volume

2,395,006 shs

Market Capitalization

$3.67 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35